Cyberonics’ VNS Depression Indication Delayed Two Years By Trial Results

Cyberonics does not expect its annual losses to grow over the next three years due to the failure of a pivotal trial to demonstrate the efficacy of the NeuroCybernetic Prosthesis (NCP) vagus nerve stimulation (VNS) system in treating depression